State Food and Drug Administration notified 5 batches of unqualified drugs

March 30, 2017 - The State Food and Drug Administration on 30 March 2017 in its website notified 5 batches of unqualified drugs, said Shanxi Guorun Pharmaceutical Company Limited and other 4 enterprises produced 5 batches of drugs failed. The relevant provinces (autonomous regions and municipalities) Food and Drug Administration has asked the enterprises to suspend the sale and use, recall the products, and carry out rectification.

The briefing said, by the Heilongjiang Provincial Food and Drug Inspection and Testing Institute test, labeled as Shanxi Guorun Pharmaceutical Company Limited and other four enterprises to produce five batches of drugs failed.

The labeled manufacturers, drug names and production batch numbers of the unqualified products are: benproperine phosphate tablets with batch numbers 1405001 and 1504011 produced by Shanxi Guorun Pharmaceutical Co. Ltd. batch No. 160606 of Benproperine Phosphate Capsules. The unqualified items include dissolution, content uniformity and content determination.

For the above unqualified drugs, the relevant provinces (autonomous regions and municipalities) Food and Drug Administration has taken seizure and other control measures, requiring enterprises to suspend the sale and use, recall the products, and carry out rectification.

The State Food and Drug Administration requires the production enterprise location of the provincial (autonomous regions and municipalities) Food and Drug Administration on the above enterprises in accordance with the "Chinese People's Republic of China *** and the State Drug Administration Law" 73, 74, 75 and other provisions of the production and sale of unqualified drugs of illegal behavior for investigation, within three months of the public on the production and sale of unqualified drugs related to the enterprise or unit of the Handling results, the relevant situation promptly reported to the General Administration.

Administration of Food and Drug Administration (AFDA) notified 35 batches of Chinese medicine tablets duchene were unqualified

March 27, 2017The State Food and Drug Administration (SFDA) has recently issued a notice that 35 batches of Chinese medicine tablets duchene, labeled as produced by Beijing Tonglentang (Bozhou) Drinking Tablets Limited Liability Company (BZLLC) and other enterprises, were unqualified.

According to the notice, the detected unqualified products involved Beijing Tongrentang (Bozhou) Drinking Tablets Limited Liability Company, Hangzhou Huadong Traditional Chinese Medicine Drinking Tablets Company Limited, Anguo Qi'an Pharmaceutical Company Limited, Xi'an Traditional Chinese Medicine Drinking Tablets Factory Company Limited and other enterprises, the unqualified items include content determination, properties.

For the above unqualified Chinese medicine tablets, the relevant provincial Food and Drug Administration has taken seizure and other control measures, requiring enterprises to suspend the sale and use, recall the product, and make corrections.

The General Administration of Food and Drug Administration asked the provincial Food and Drug Administration, where the manufacturer is located, in accordance with the relevant provisions of the production and sale of unqualified products for investigation of violations, and within three months to make public the results of the treatment.

According to the notice, Xi'an Traditional Chinese Medicine Drinking Tablets Factory Co., Ltd. and other labeled manufacturers denied that the unqualified products were produced by the enterprise. For enterprises to object to the authenticity of the product, the General Administration of Food and Drug Administration pointed out that enterprises can be proposed to the local provincial Food and Drug Administration, the local provincial Food and Drug Administration on the production and sales of enterprises to investigate and verify the situation, and the situation will be notified to the sampled units of the local provincial Food and Drug Administration. Sampled units of the local provincial Food and Drug Administration to receive notification, to immediately investigate the case, trace the source of the product. If the labeled production company production, by the relevant provincial Food and Drug Administration on the production of heavy penalties.